Literature DB >> 9349670

Changes in the concentration of amino acids in serum and cerebrospinal fluid of patients with Parkinson's disease.

J Mally1, G Szalai, T W Stone.   

Abstract

The concentrations of sixteen amino acids have been measured in the serum and cerebrospinal fluid (CSF) of patients with Parkinson's disease and compared with those of control subjects. The levels of most amino acids were not different between the two groups, but the level of glutamate in CSF was decreased significantly, while the level of glutamine was increased. The results may be consistent with an alteration of glutamate neurotransmission in Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9349670     DOI: 10.1016/s0022-510x(97)00119-6

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  25 in total

1.  Amino acids and biogenic amines in cerebrospinal fluid of patients with Parkinson's disease.

Authors:  S Engelborghs; B Marescau; P P De Deyn
Journal:  Neurochem Res       Date:  2003-08       Impact factor: 3.996

Review 2.  Biomarkers for cognitive impairment in Parkinson disease.

Authors:  Min Shi; Bertrand R Huber; Jing Zhang
Journal:  Brain Pathol       Date:  2010-05       Impact factor: 6.508

3.  Subcellular and subsynaptic localization of group I metabotropic glutamate receptors in the nucleus accumbens of cocaine-treated rats.

Authors:  D A Mitrano; C Arnold; Y Smith
Journal:  Neuroscience       Date:  2008-03-29       Impact factor: 3.590

4.  Inhibition of neuronal cell mitochondrial complex I with rotenone increases lipid β-oxidation, supporting acetyl-coenzyme A levels.

Authors:  Andrew J Worth; Sankha S Basu; Nathaniel W Snyder; Clementina Mesaros; Ian A Blair
Journal:  J Biol Chem       Date:  2014-08-12       Impact factor: 5.157

5.  Metabolic Alterations and the Protective Effect of Punicalagin Against Glutamate-Induced Oxidative Toxicity in HT22 Cells.

Authors:  Kavitha Pathakoti; Lavanya Goodla; Manjunath Manubolu; Tewin Tencomnao
Journal:  Neurotox Res       Date:  2017-01-09       Impact factor: 3.911

6.  NMR Metabolomics Analysis of Parkinson's Disease.

Authors:  Shulei Lei; Robert Powers
Journal:  Curr Metabolomics       Date:  2013

7.  Neurometabolic effects of ACTH on free amino compounds in opsoclonus-myoclonus syndrome.

Authors:  M R Pranzatelli; E D Tate; J M Crowley; B Toennies; M Creer
Journal:  Neuropediatrics       Date:  2008-11-07       Impact factor: 1.947

8.  Metabolic profiling of Parkinson's disease: evidence of biomarker from gene expression analysis and rapid neural network detection.

Authors:  Shiek Ssj Ahmed; Winkins Santosh; Suresh Kumar; Hema T Thanka Christlet
Journal:  J Biomed Sci       Date:  2009-07-13       Impact factor: 8.410

9.  Changes in amino acids and nitric oxide concentration in cerebrospinal fluid during labor pain.

Authors:  Rama Sethuraman; Tat-Leang Lee; Jen-Wun Chui; Shinro Tachibana
Journal:  Neurochem Res       Date:  2006-08-29       Impact factor: 4.414

Review 10.  Neurochemical approaches in the laboratory diagnosis of Parkinson and Parkinson dementia syndromes: a review.

Authors:  Sarah Jesse; Petra Steinacker; Stefan Lehnert; Frank Gillardon; Bastian Hengerer; Markus Otto
Journal:  CNS Neurosci Ther       Date:  2009-03-09       Impact factor: 5.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.